FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

126098001: Conjugated estrogens (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
9262019 Conjugated estrogen en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
730016013 Conjugated estrogen (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
9262019 Conjugated estrogen en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
9262019 Conjugated estrogen en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
9262019 Conjugated estrogen en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
473613015 Conjugated oestrogen en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
473613015 Conjugated oestrogen en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
730016013 Conjugated estrogen (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
730016013 Conjugated estrogen (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
730016013 Conjugated estrogen (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3672146018 Conjugated estrogens (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3672147010 Conjugated estrogens en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
30121000188111 estrogènes conjuguès fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
30121000188111 estrogènes conjuguès fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
estrogènes conjuguès Is a estrogeno false Inferred relationship Existential restriction modifier (core metadata concept)
estrogènes conjuguès Has disposition Estrogen false Inferred relationship Existential restriction modifier (core metadata concept)
estrogènes conjuguès Has disposition Gonadal hormone false Inferred relationship Existential restriction modifier (core metadata concept)
estrogènes conjuguès Is a Steroid hormone true Inferred relationship Existential restriction modifier (core metadata concept)
estrogènes conjuguès Is a Substance with estrogen receptor agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
estrogènes conjuguès Has disposition Estrogen receptor agonist true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Conjugated estrogen-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated oestrogens adverse reaction Causative agent (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Allergy to conjugated estrogen Causative agent (attribute) False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Conjugated estrogens [endocrine use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Conjugated estrogens 625micrograms tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Conjugated estrogen 1.25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Conjug estrogen [topical vaginal use] The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 625 microgram/1 gram conventional release vaginal cream (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone 5mg / Conjugated Estrogens 625microgram tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 900 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Conjugated estrogen 450 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 300 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Conjugated estrogen- and medroxyprogesterone-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogens 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogens 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Conjugated estrogen- and norgestrel-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogens synthetic A Is a False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Conjugated estrogens synthetic B Is a False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely conjugated estrogen 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept)
Allergy to conjugated estrogen Causative agent (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen-containing product in vaginal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Bazedoxifene- and conjugated estrogen-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Bazedoxifene- and conjugated estrogen-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogens 625micrograms tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogens 625micrograms tablet (substance) Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 1.25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 1.25 mg oral tablet Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 2
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet Has basis of strength substance (attribute) False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely conjugated estrogen 900 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 900 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 450 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 450 microgram oral tablet Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 300 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 300 microgram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogens 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogens 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet Has basis of strength substance (attribute) False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogens 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely conjugated estrogens 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely conjugated estrogens 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely conjugated estrogen 900 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 450 microgram oral tablet Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 300 microgram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogens 300 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely conjugated estrogens 450 microgram and medroxyprogesterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely conjugated estrogen 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogens 625micrograms tablet (substance) Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 1.25 mg oral tablet Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet Has precise active ingredient False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 2
Conjugated estrogen-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 5 milligram/1 each conventional release oral tablet Has precise active ingredient False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 10 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing conjugated estrogen and medroxyprogesterone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing conjugated estrogen and norgestrel in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing conjugated estrogen in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient False estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 625 microgram/1 gram conventional release vaginal cream (clinical drug) Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 625 microgram/1 gram conventional release vaginal cream (clinical drug) Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only bazedoxifene and conjugated estrogen (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only conjugated estrogen and medroxyprogesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen and norgestrel only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen and medroxyprogesterone only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only conjugated estrogen and norgestrel in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only conjugated estrogen in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only conjugated estrogen in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen only product in vaginal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Bazedoxifene and conjugated estrogen only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 mg oral tablet Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 5 mg oral tablet Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 625 microgram and esterified estrogen 625 microgram and medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 25 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing conjugated estrogen and esterified estrogen and medroxyprogesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only conjugated estrogen and esterified estrogen and medroxyprogesterone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing conjugated estrogen and esterified estrogen and medroxyprogesterone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen and esterified estrogen and medroxyprogesterone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely conjugated estrogen 300 microgram and medroxyprogesterone acetate 1.5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 450 microgram and medroxyprogesterone acetate 1.5 mg oral tablet Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 450 microgram and medroxyprogesterone acetate 1.5 mg oral tablet Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 2.5 mg oral tablet Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 625 microgram and medroxyprogesterone acetate 2.5 mg oral tablet Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet Has precise active ingredient True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet Has basis of strength substance (attribute) True estrogènes conjuguès Inferred relationship Existential restriction modifier (core metadata concept) 1

Page 1 of 2 End

This concept is not in any reference sets

Back to Start